My apologies for saying limit of 10% daily volume.
Yesterday's buyback volume is way higher than I expected.
The high buyback means the board believes current share price is undervalued.
Current cash position is around $210m, royalties payment plus bank interest are around $18m, which is about to cover current expenditure. However the expenditure should increase as PMS proceeds to the Phase 3 trial next year, imo. NEU is to receive additional US$100m next quarter, so cash position will be well above $300m. I won't be surprised if the share buyback is upsized at next AGM in May 2025.
All imo.
- Forums
- ASX - By Stock
- NEU Vs Reata
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.14%
!
$13.31

My apologies for saying limit of 10% daily volume. Yesterday's...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.31 |
Change
0.770(6.14%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $19.76M | 1.453M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | $13.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.33 | 3716 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 13.300 |
2 | 10200 | 13.200 |
1 | 2500 | 13.190 |
2 | 1750 | 13.180 |
1 | 50 | 13.170 |
Price($) | Vol. | No. |
---|---|---|
13.330 | 3716 | 1 |
13.370 | 3716 | 1 |
13.390 | 600 | 1 |
13.400 | 3783 | 2 |
13.430 | 3716 | 1 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online